{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:42:55Z","timestamp":1792716175854,"version":"4.5.0"},"reference-count":146,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2017,12,14]],"date-time":"2017-12-14T00:00:00Z","timestamp":1513209600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0006052","type":"journal-article","created":{"date-parts":[[2017,12,14]],"date-time":"2017-12-14T18:26:28Z","timestamp":1513275988000},"page":"e0006052","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":875,"title":["Drug resistance and treatment failure in leishmaniasis: A 21st century challenge"],"prefix":"10.1371","volume":"11","author":[{"given":"Alicia","family":"Ponte-Sucre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Gamarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Claude","family":"Dujardin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rogelio","family":"L\u00f3pez-V\u00e9lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Garc\u00eda-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew W.","family":"Pountain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy","family":"Mwenechanya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6697-9739","authenticated-orcid":true,"given":"Barbara","family":"Papadopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,12,14]]},"reference":[{"key":"ref1","unstructured":"WHO (<ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/leishmaniasis\/en\/\" xlink:type=\"simple\">http:\/\/www.who.int\/leishmaniasis\/en\/<\/ext-link>). Accessed on 10 May 2017."},{"issue":"10","key":"ref2","doi-asserted-by":"crossref","first-page":"e1284","DOI":"10.1371\/journal.pntd.0001284","article-title":"Incidence of symptomatic and asymptomatic <italic>Leishmania donovani<\/italic> infections in high-endemic foci in India and Nepal: a prospective study","volume":"5","author":"B Ostyn","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"issue":"10","key":"ref3","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1590\/0074-02760160138","article-title":"Asymptomatic infection with American cutaneous leishmaniasis: epidemiological and immunological studies","volume":"111","author":"FJ Andrade-Narvaez","year":"2016","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"10","key":"ref4","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1111\/j.1469-0691.2011.03630.x","article-title":"Leishmaniasis chemotherapy\u2014challenges and opportunities","volume":"17","author":"SL Croft","year":"2011","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"ref5","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jaad.2009.06.088","article-title":"New World cutaneous leishmaniasis: updated review of current and future diagnosis and treatment","volume":"63","author":"P Mitropoulos","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"ref6","unstructured":"WHO <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/apps.who.int\/iris\/handle\/10665\/255104\" xlink:type=\"simple\">http:\/\/apps.who.int\/iris\/handle\/10665\/255104<\/ext-link>. Accessed on 10 May 2017."},{"issue":"4","key":"ref7","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/cid\/cis474","article-title":"Efficacy of miltefosine in the treatment of visceral leishmaniasis in India after a decade of use","volume":"55","author":"S Sundar","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"11","key":"ref8","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1093\/cid\/cit102","article-title":"Increasing failure of miltefosine in the treatment of Kala-azar in Nepal and the potential role of parasite drug resistance, reinfection, or noncompliance","volume":"56","author":"S Rijal","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"4","key":"ref9","doi-asserted-by":"crossref","first-page":"e0154101","DOI":"10.1371\/journal.pone.0154101","article-title":"Genomic and Molecular Characterization of Miltefosine Resistance in <italic>Leishmania infantum<\/italic> Strains with Either Natural or Acquired Resistance through Experimental Selection of Intracellular Amastigotes","volume":"11","author":"A Mondelaers","year":"2016","journal-title":"PLoS ONE"},{"issue":"1","key":"ref10","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13071-017-1969-z","article-title":"Laboratory confirmed miltefosine resistant cases of visceral leishmaniasis from India","volume":"10","author":"S Srivastava","year":"2017","journal-title":"Parasit Vectors"},{"issue":"4","key":"ref11","doi-asserted-by":"crossref","first-page":"704","DOI":"10.3201\/eid1804.110841","article-title":"<italic>Leishmania<\/italic> resistance to miltefosine associated with genetic marker","volume":"18","author":"S Cojean","year":"2012","journal-title":"Emerg Infect Dis"},{"issue":"7","key":"ref12","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1093\/jac\/dkw096","article-title":"Evidence of a drug-specific impact of experimentally selected paromomycin and miltefosine resistance on parasite fitness in <italic>Leishmania infantum<\/italic>","volume":"71","author":"S Hendrickx","year":"2016","journal-title":"J Antimicrob Chemother"},{"issue":"12","key":"ref13","doi-asserted-by":"crossref","first-page":"e1974","DOI":"10.1371\/journal.pntd.0001974","article-title":"<italic>Leishmania donovani<\/italic> develops resistance to drug combinations","volume":"6","author":"R Garc\u00eda-Hern\u00e1ndez","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"ref14","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.molbiopara.2008.12.007","article-title":"Paromomycin: uptake and resistance in <italic>Leishmania donovani<\/italic>","volume":"164","author":"A Jhingran","year":"2009","journal-title":"Mol Biochem Parasitol"},{"issue":"5","key":"ref15","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1128\/AAC.01574-13","article-title":"Elucidation of cellular mechanisms involved in experimental paromomycin resistance in <italic>Leishmania donovani<\/italic>","volume":"58","author":"V Bhandari","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"ref16","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1128\/CMR.00061-07","article-title":"The relationship between leishmaniasis and AIDS: the second 10 years","volume":"21","author":"J Alvar","year":"2008","journal-title":"Clin Microbiol Rev"},{"issue":"6","key":"ref17","doi-asserted-by":"crossref","first-page":"e100220","DOI":"10.1371\/journal.pone.0100220","article-title":"Failure of miltefosine treatment for visceral leishmaniasis in children and men in South-East Asia","volume":"9","author":"B Ostyn","year":"2014","journal-title":"PLoS ONE"},{"issue":"1","key":"ref18","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/infdis\/jiu039","article-title":"Failure of miltefosine in visceral leishmaniasis is associated with low drug exposure","volume":"210","author":"TP Dorlo","year":"2014","journal-title":"J Infect Dis"},{"issue":"7","key":"ref19","doi-asserted-by":"crossref","first-page":"3864","DOI":"10.1128\/AAC.00292-12","article-title":"Optimal dosing of miltefosine in children and adults with visceral leishmaniasis","volume":"56","author":"TP Dorlo","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"ref20","unstructured":"Resources for Health Professionals. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.cdc.gov\/parasites\/leishmaniasis\/health_professionals\" xlink:type=\"simple\">https:\/\/www.cdc.gov\/parasites\/leishmaniasis\/health_professionals<\/ext-link>. Accessed on 10 May 2017."},{"issue":"1","key":"ref21","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/1574-6976.12032","article-title":"Drug resistance in vectorborne parasites: multiple actors and scenarios for an evolutionary arms race","volume":"38","author":"M Vanaerschot","year":"2014","journal-title":"FEMS Microbiol Rev"},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/infdis\/jiv354","article-title":"Association of the Endobiont Double-Stranded RNA Virus LRV1 With Treatment Failure for Human Leishmaniasis Caused by <italic>Leishmania braziliensis<\/italic> in Peru and Bolivia","volume":"213","author":"V Adaui","year":"2016","journal-title":"J Infect Dis"},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/infdis\/jiv355","article-title":"Presence of <italic>Leishmania<\/italic> RNA Virus 1 in <italic>Leishmania guyanensis<\/italic> Increases the Risk of First-Line Treatment Failure and Symptomatic Relapse","volume":"213","author":"E Bourreau","year":"2016","journal-title":"J Infect Dis"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3389\/fcimb.2012.00099","article-title":"<italic>Leishmania<\/italic> RNA virus: when the host pays the toll","volume":"2","author":"MA Hartley","year":"2012","journal-title":"Front Cell Infect Microbiol"},{"issue":"4","key":"ref25","doi-asserted-by":"crossref","first-page":"436","DOI":"10.4269\/ajtmh.1998.58.436","article-title":"Clinicoepidemiologic characteristics, prognostic factors, and survival analysis of patients coinfected with human immunodeficiency virus and <italic>Leishmania<\/italic> in an area of Madrid, Spain","volume":"58","author":"R Lopez-Velez","year":"1998","journal-title":"Am J Trop Med Hyg"},{"issue":"4","key":"ref26","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/1469-0691.12556","article-title":"Leishmaniasis in immunosuppressed individuals","volume":"20","author":"J van Griensven","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"12","key":"ref27","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1086\/518041","article-title":"Influence of <italic>Leishmania<\/italic> (<italic>Viannia<\/italic>) species on the response to antimonial treatment in patients with American tegumentary leishmaniasis","volume":"195","author":"J Arevalo","year":"2007","journal-title":"J Infect Dis"},{"key":"ref28","first-page":"30","article-title":"Diffuse cutaneous leishmaniasis in Venezuela","volume":"79","author":"O Zerpa","year":"2009","journal-title":"Gaz m\u00e9d Bahia"},{"issue":"5","key":"ref29","doi-asserted-by":"crossref","first-page":"456","DOI":"10.4269\/ajtmh.2001.65.456","article-title":"Comparison of cutaneous leishmaniasis due to <italic>Leishmania<\/italic> (<italic>Viannia<\/italic>) <italic>braziliensis<\/italic> and <italic>L<\/italic>. (<italic>V<\/italic>.) <italic>guyanensis<\/italic> in Brazil: therapeutic response to meglumine antimoniate","volume":"65","author":"GA Romero","year":"2001","journal-title":"Am J Trop Med Hyg"},{"key":"ref30","first-page":"431","article-title":"Drug Resist. <italic>Leishmania<\/italic> parasites. Consequences, Mol. Mech. possible Treat","author":"A Ponte-Sucre","year":"2013"},{"issue":"3","key":"ref31","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.tips.2009.11.005","article-title":"Impact of poor-quality medicines in the &apos;developing&apos; world","volume":"31","author":"PN Newton","year":"2010","journal-title":"Trends Pharmacol Sci"},{"issue":"6","key":"ref32","doi-asserted-by":"crossref","first-page":"e1656","DOI":"10.1371\/journal.pntd.0001656","article-title":"Prediction score for antimony treatment failure in patients with ulcerative leishmaniasis lesions","volume":"6","author":"C Valencia","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"ref33","doi-asserted-by":"crossref","first-page":"e2675","DOI":"10.1371\/journal.pntd.0002675","article-title":"Significantly lower anti-<italic>Leishmania<\/italic> IgG responses in Sudanese versus Indian visceral leishmaniasis","volume":"8","author":"T Bhattacharyya","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"ref34","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s12879-017-2318-8","article-title":"Development of a rapid loop-mediated isothermal amplification assay for diagnosis and assessment of cure of <italic>Leishmania<\/italic> infection","volume":"17","author":"S Verma","year":"2017","journal-title":"BMC Infect Dis"},{"issue":"7","key":"ref35","doi-asserted-by":"crossref","first-page":"e0005713","DOI":"10.1371\/journal.pntd.0005713","article-title":"Clinical and parasitological factors in parasite persistence after treatment and clinical cure of cutaneous leishmaniasis","volume":"11","author":"AJ Mart\u00ednez-Valencia","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"issue":"Suppl 1","key":"ref36","doi-asserted-by":"crossref","first-page":"S173","DOI":"10.1016\/S0035-9203(02)90072-6","article-title":"Parasitological and immunological follow-up of American tegumentary leishmaniasis patients","volume":"96","author":"SG Coutinho","year":"2002","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"9","key":"ref37","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1086\/383321","article-title":"Miltefosine for new world cutaneous leishmaniasis","volume":"38","author":"J Soto","year":"2004","journal-title":"Clin Infect Dis"},{"key":"ref38","first-page":"199","article-title":"Drug resistance in <italic>Leishmania<\/italic> parasites. Consequences, Molecular Mechanisms, and possible treatments","author":"O Zerpa","year":"2013"},{"issue":"9","key":"ref39","doi-asserted-by":"crossref","first-page":"e1227","DOI":"10.1371\/journal.pntd.0001227","article-title":"Visceral leishmaniasis and arsenic: an ancient poison contributing to antimonial treatment failure in the Indian subcontinent?","volume":"5","author":"MR Perry","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"ref40","doi-asserted-by":"crossref","first-page":"e0003518","DOI":"10.1371\/journal.pntd.0003518","article-title":"Arsenic exposure and outcomes of antimonial treatment in visceral leishmaniasis patients in Bihar, India: a retrospective cohort study","volume":"9","author":"MR Perry","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"issue":"10","key":"ref41","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1128\/AAC.47.10.3073-3079.2003","article-title":"Antimony uptake systems in the protozoan parasite <italic>Leishmania<\/italic> and accumulation differences in antimony-resistant parasites","volume":"47","author":"C Brochu","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"ref42","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1093\/jac\/dkp468","article-title":"Assessing aquaglyceroporin gene status and expression profile in antimony-susceptible and -resistant clinical isolates of <italic>Leishmania donovani<\/italic> from India","volume":"65","author":"S Mandal","year":"2010","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"ref43","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1111\/j.1365-2958.2005.04782.x","article-title":"mModulation in aquaglyceroporin AQP1 gene transcript levels in drug-resistant <italic>Leishmania<\/italic>","volume":"57","author":"N Marquis","year":"2005","journal-title":"Mol Microbiol"},{"issue":"1","key":"ref44","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1128\/CMR.19.1.111-126.2006","article-title":"Drug resistance in leishmaniasis","volume":"19","author":"SL Croft","year":"2006","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"ref45","first-page":"411","article-title":"Drug resistance mechanisms in clinical isolates of <italic>Leishmania donovani<\/italic>","volume":"123","author":"N Singh","year":"2006","journal-title":"Indian J Med Res"},{"key":"ref46","first-page":"617521","article-title":"Drug resistance in visceral leishmaniasis","author":"HC Maltezou","year":"2010","journal-title":"J Biomed Biotechnol"},{"issue":"28","key":"ref47","doi-asserted-by":"crossref","first-page":"26301","DOI":"10.1074\/jbc.M102351200","article-title":"The <italic>Leishmania<\/italic> ATP-binding cassette protein PGPA is an intracellular metal-thiol transporter ATPase","volume":"276","author":"D L\u00e9gar\u00e9","year":"2001","journal-title":"J Biol Chem"},{"issue":"Pt 2","key":"ref48","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1099\/jmm.0.46841-0","article-title":"Molecular mechanisms of antimony resistance in <italic>Leishmania<\/italic>","volume":"56","author":"Ashutosh","year":"2007","journal-title":"J Med Microbiol"},{"issue":"5","key":"ref49","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1128\/AAC.49.5.1988-1993.2005","article-title":"Role of the ABC transporter MRPA (PGPA) in antimony resistance in <italic>Leishmania infantum<\/italic> axenic and intracellular amastigotes","volume":"49","author":"K El Fadili","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"ref50","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0166-6851(03)00162-2","article-title":"Functional genetic identification of PRP1, an ABC transporter superfamily member conferring pentamidine resistance in <italic>Leishmania major<\/italic>","volume":"130","author":"AC Coelho","year":"2003","journal-title":"Mol Biochem Parasitol"},{"issue":"8","key":"ref51","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1128\/AAC.00211-13","article-title":"A new ABC half-transporter in <italic>Leishmania major<\/italic> is involved in resistance to antimony","volume":"57","author":"JI Manzano","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"ref52","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1128\/AAC.02813-15","article-title":"The LABCG2 Transporter from the Protozoan Parasite <italic>Leishmania<\/italic> Is Involved in Antimony Resistance","volume":"60","author":"A Perea","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"ref53","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1128\/AAC.01563-07","article-title":"Roles of trypanothione S-transferase and tryparedoxin peroxidase in resistance to antimonials","volume":"52","author":"S Wyllie","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"ref54","doi-asserted-by":"crossref","first-page":"681","DOI":"10.4269\/ajtmh.2007.76.681","article-title":"Characterization of natural antimony resistance in <italic>Leishmania donovani<\/italic> isolates","volume":"76","author":"MK Mittal","year":"2007","journal-title":"Am J Trop Med Hyg"},{"issue":"Pt 12","key":"ref55","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1017\/S0031182007003150","article-title":"Increased levels of thiols protect antimony unresponsive <italic>Leishmania donovani<\/italic> field isolates against reactive oxygen species generated by trivalent antimony","volume":"134","author":"G Mandal","year":"2007","journal-title":"Parasitology"},{"issue":"7","key":"ref56","doi-asserted-by":"crossref","first-page":"E575","DOI":"10.1073\/pnas.1213839110","article-title":"Antimony-resistant but not antimony-sensitive <italic>Leishmania donovani<\/italic> up-regulates host IL-10 to overexpress multidrug-resistant protein 1","volume":"110","author":"B Mukherjee","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"ref57","first-page":"16","article-title":"Sodium stibogluconate: therapeutic use in the management of leishmaniasis","volume":"45","author":"J Roychoudhury","year":"2008","journal-title":"Indian J of Biochemistry & Biophysics"},{"issue":"9","key":"ref58","doi-asserted-by":"crossref","first-page":"e3136","DOI":"10.1371\/journal.pntd.0003136","article-title":"Visceral leishmaniasis and HIV coinfection in Latin America","volume":"8","author":"JA Lindoso","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"issue":"Suppl 2","key":"ref59","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1365-3156.2010.02562.x","article-title":"Management of visceral leishmaniasis in rural primary health care services in Bihar, India","volume":"15","author":"E Hasker","year":"2010","journal-title":"Trop Med Int Health"},{"issue":"1","key":"ref60","first-page":"1","article-title":"Mucosal leishmaniasis. Current scenario and prospects for treatment","volume":"105","author":"VS Amato","year":"2008","journal-title":"Acta Trop"},{"issue":"1","key":"ref61","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.meegid.2008.09.005","article-title":"Multilocus microsatellite typing (MLMT) reveals genetic homogeneity of <italic>Leishmania donovani<\/italic> strains in the Indian subcontinent","volume":"9","author":"MZ Alam","year":"2009","journal-title":"Infect Genet Evol"},{"key":"ref62","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.12613","article-title":"Evolutionary genomics of epidemic visceral leishmaniasis in the Indian subcontinent","volume":"5","author":"H Imamura","year":"2016","journal-title":"Elife"},{"issue":"3","key":"ref63","doi-asserted-by":"crossref","first-page":"e0005420","DOI":"10.1371\/journal.pntd.0005420","article-title":"Single locus genotyping to track <italic>Leishmania donovani<\/italic> in the Indian subcontinent: Application in Nepal","volume":"11","author":"K Rai","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"ref64","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.pt.2016.11.003","article-title":"Exploiting Knowledge on <italic>Leishmania<\/italic> Drug Resistance to Support the Quest for New Drugs","volume":"33","author":"A Hefnawy","year":"2017","journal-title":"Trends Parasitol"},{"issue":"11","key":"ref65","doi-asserted-by":"crossref","first-page":"e1405","DOI":"10.1371\/journal.pntd.0001405","article-title":"Visceral leishmaniasis in the Indian subcontinent: modelling epidemiology and control","volume":"5","author":"A Stauch","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"ref66","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.actatropica.2007.05.005","article-title":"Comparison of miltefosine and meglumine antimoniate for the treatment of zoonotic cutaneous leishmaniasis (ZCL) by a randomized clinical trial in Iran","volume":"103","author":"M Mohebali","year":"2007","journal-title":"Acta Trop"},{"issue":"12","key":"ref67","doi-asserted-by":"crossref","first-page":"e912","DOI":"10.1371\/journal.pntd.0000912","article-title":"Miltefosine in the treatment of cutaneous leishmaniasis caused by <italic>Leishmania braziliensis<\/italic> in Brazil: a randomized and controlled trial","volume":"4","author":"PR Machado","journal-title":"PLoS Negl Trop Dis"},{"issue":"12","key":"ref68","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1017\/S0031182013000140","article-title":"(Post-) Genomic approaches to tackle drug resistance in <italic>Leishmania<\/italic>","volume":"140","author":"M Berg","year":"2013","journal-title":"Parasitology"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.12688\/f1000research.9218.1","article-title":"Plasticity of the <italic>Leishmania<\/italic> genome leading to gene copy number variations and drug resistance","volume":"5","author":"MN Laffitte","year":"2016","journal-title":"F1000Res"},{"issue":"5","key":"ref70","doi-asserted-by":"crossref","first-page":"e1001868","DOI":"10.1371\/journal.pbio.1001868","article-title":"Genome-wide stochastic adaptive DNA amplification at direct and inverted DNA repeats in the parasite <italic>Leishmania<\/italic>","volume":"12","author":"JM Ubeda","year":"2014","journal-title":"PLoS Biol"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1042\/bse0510031","article-title":"Gene expression regulation in trypanosomatids","volume":"51","author":"JG De Gaudenzi","year":"2011","journal-title":"Essays Biochem"},{"issue":"2","key":"ref72","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S1471-4922(01)02199-7","article-title":"How to succeed in parasitic life without sex? Asking <italic>Leishmania<\/italic>","volume":"18","author":"K Victoir","year":"2002","journal-title":"Trends Parasitol"},{"issue":"7","key":"ref73","doi-asserted-by":"crossref","first-page":"R115","DOI":"10.1186\/gb-2008-9-7-r115","article-title":"Modulation of gene expression in drug resistant <italic>Leishmania<\/italic> is associated with gene amplification, gene deletion and chromosome aneuploidy","volume":"9","author":"JM Ubeda","year":"2008","journal-title":"Genome Biol"},{"issue":"2","key":"ref74","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1093\/jac\/dkl494","article-title":"Role of ABC transporter MRPA, gamma-glutamylcysteine synthetase and ornithine decarboxylase in natural antimony-resistant isolates of <italic>Leishmania donovani<\/italic>","volume":"59","author":"A Mukherjee","year":"2007","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"ref75","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1093\/nar\/gkn1069","article-title":"Gene expression modulation is associated with gene amplification, supernumerary chromosomes and chromosome loss in antimony-resistant <italic>Leishmania infantum<\/italic>","volume":"37","author":"P Leprohon","year":"2009","journal-title":"Nucleic Acids Res"},{"issue":"18","key":"ref76","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1093\/nar\/27.18.3653","article-title":"Role of the locus and of the resistance gene on gene amplification frequency in methotrexate resistant <italic>Leishmania tarentolae<\/italic>","volume":"27","author":"C K\u00fcndig","year":"1999","journal-title":"Nucleic Acids Res"},{"issue":"18","key":"ref77","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.1093\/nar\/21.18.4305","article-title":"Frequent amplification of a short chain dehydrogenase gene as part of circular and linear amplicons in methotrexate resistant <italic>Leishmania<\/italic>","volume":"21","author":"B Papadopoulou","year":"1993","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"ref78","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/j.1365-2958.2007.05653.x","article-title":"A novel ATP-binding cassette transporter from <italic>Leishmania<\/italic> is involved in transport of phosphatidylcholine analogues and resistance to alkyl-phospholipids","volume":"64","author":"E Castanys-Mu\u00f1oz","year":"2007","journal-title":"Mol Microbiol"},{"issue":"4","key":"ref79","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1002\/j.1460-2075.1990.tb08206.x","article-title":"The amplified H circle of methotrexate-resistant <italic>Leishmania tarentolae<\/italic> contains a novel P-glycoprotein gene","volume":"9","author":"M Ouellette","year":"1990","journal-title":"EMBO J"},{"issue":"9","key":"ref80","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.pt.2014.07.002","article-title":"Parasexuality and mosaic aneuploidy in <italic>Leishmania<\/italic>: alternative genetics","volume":"30","author":"Y Sterkers","year":"2014","journal-title":"Trends Parasitol"},{"issue":"3","key":"ref81","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00599-17","article-title":"Modulation of aneuploidy in <italic>Leishmania donovani<\/italic> during adaptation to different in vitro and in vivo environments, and its impact on gene expression","volume":"8","author":"F Dumetz","year":"2017","journal-title":"mBio"},{"issue":"9","key":"ref82","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.pt.2012.06.003","article-title":"Adaptive mechanisms in pathogens: universal aneuploidy in <italic>Leishmania<\/italic>","volume":"28","author":"A Mannaert","year":"2012","journal-title":"Trends Parasitol"},{"issue":"4","key":"ref83","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1086\/318122","article-title":"Short-course of oral miltefosine for treatment of visceral leishmaniasis","volume":"31","author":"S Sundar","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"22","key":"ref84","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1056\/NEJMoa021556","article-title":"Oral miltefosine for Indian visceral leishmaniasis","volume":"347","author":"S Sundar","year":"2002","journal-title":"N Engl J Med"},{"issue":"3","key":"ref85","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2174\/138920009787846332","article-title":"Cellular transport and lipid interactions of miltefosine","volume":"10","author":"G Barratt","year":"2009","journal-title":"Curr Drug Metab"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0166-6851(00)00278-4","article-title":"Ether\u2013lipid (alkyl-phospholipid) metabolism and the mechanism of action of ether\u2013lipid analogues in <italic>Leishmania<\/italic>","volume":"111","author":"H Lux","year":"2000","journal-title":"Mol Biochem Parasitol"},{"issue":"4","key":"ref87","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1128\/AAC.01415-06","article-title":"Miltefosine (hexadecylphosphocholine) inhibits cytochrome c oxidase in <italic>Leishmania donovani<\/italic> promastigotes","volume":"51","author":"JR Luque-Ortega","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"ref88","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1128\/AAC.48.3.852-859.2004","article-title":"Miltefosine induces apoptosis-like death in <italic>Leishmania donovani<\/italic> promastigotes","volume":"48","author":"C Paris","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"ref89","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1093\/jac\/dks275","article-title":"Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis","volume":"67","author":"TP Dorlo","year":"2012","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"ref90","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1128\/AAC.48.8.3010-3015.2004","article-title":"Possible mechanism of miltefosine-mediated death of <italic>Leishmania donovani<\/italic>","volume":"48","author":"NK Verma","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"49965","DOI":"10.1074\/jbc.M308352200","article-title":"Functional cloning of the miltefosine transporter. A novel P-type phospholipid translocase from <italic>Leishmania<\/italic> involved in drug resistance","volume":"278","author":"FJ Perez-Victoria","year":"2003","journal-title":"J Biol Chem"},{"key":"ref92","doi-asserted-by":"crossref","first-page":"23766","DOI":"10.1074\/jbc.M605214200","article-title":"Phospholipid translocation and miltefosine potency require both <italic>L<\/italic>. <italic>donovani<\/italic> miltefosine transporter and the new protein LdRos3 in <italic>Leishmania<\/italic> parasites","volume":"281","author":"FJ Perez-Victoria","year":"2006","journal-title":"J Biol Chem"},{"key":"ref93","article-title":"Drug Resistance in <italic>Leishmania<\/italic> parasites","author":"F Gamarro","year":"2013"},{"issue":"5","key":"ref94","first-page":"733","article-title":"Miltefosine in the treatment of leishmaniasis: Clinical evidence for informed clinical risk management","volume":"3","author":"S Sundar","year":"2007","journal-title":"Ther Clin Risk Manag"},{"issue":"5","key":"ref95","first-page":"e00611","article-title":"Relapse after treatment with miltefosine for visceral leishmaniasis is associated with increased infectivity of the infecting <italic>Leishmania donovani<\/italic> strain","volume":"4","author":"K Rai","year":"2013","journal-title":"M MBio"},{"issue":"6","key":"ref96","doi-asserted-by":"crossref","first-page":"e100220","DOI":"10.1371\/journal.pone.0100220","article-title":"Failure of miltefosine treatment for visceral leishmaniasis in children and men in South-East Asia","volume":"9","author":"B Ostyn","year":"2014","journal-title":"PLoS ONE"},{"key":"ref97","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S0924-8579(03)00125-0","article-title":"Characterisation of <italic>Leishmania donovani<\/italic> promastigotes resistant to hexadecylphosphocholine (miltefosine)","volume":"22","author":"K Seifert","year":"2003","journal-title":"Int J Antimicrob. Agents"},{"key":"ref98","first-page":"397","article-title":"<italic>Leishmania donovani<\/italic> resistance to miltefosine involves a defective inward translocation of the drug","volume":"47","author":"FJ P\u00e9rez-Victoria","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"ref99","doi-asserted-by":"crossref","first-page":"e1512","DOI":"10.1371\/journal.pntd.0001512","article-title":"Multiple mutations in heterogeneous miltefosine-resistant <italic>Leishmania major<\/italic> population as determined by whole genome sequencing","volume":"6","author":"AC Coelho","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"ref100","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s00436-014-3755-6","article-title":"Comparative transcript expression analysis of miltefosine-sensitive and miltefosine-resistant <italic>Leishmania donovani<\/italic>","volume":"113","author":"A Kulshrestha","year":"2014","journal-title":"Parasitol Res"},{"issue":"7","key":"ref101","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.1128\/AAC.00478-16","article-title":"Genomic Appraisal of the Multifactorial Basis for In Vitro Acquisition of Miltefosine Resistance in <italic>Leishmania donovani<\/italic>","volume":"60","author":"P Vacchina","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"ref102","doi-asserted-by":"crossref","first-page":"e0154101","DOI":"10.1371\/journal.pone.0154101","article-title":"Genomic and molecular characterization of miltefosine resistance in <italic>Leishmania infantum<\/italic> Strains with Either Natural or Acquired Resistance through Experimental Selection of Intracellular Amastigotes","volume":"11","author":"A Mondelaers","year":"2016","journal-title":"PLoS ONE"},{"key":"ref103","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ijantimicag.2007.05.007","article-title":"Inactivation of the miltefosine transporter, LdMT, causes miltefosine resistance that is conferred to the amastigote stage of <italic>Leishmania donovani<\/italic> and persists in vivo","volume":"30","author":"K Seifert","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"ref104","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1128\/AAC.45.9.2468-2474.2001","article-title":"Alkyl-lysophospholipid resistance in multidrug-resistant <italic>Leishmania tropica<\/italic> and chemosensitization by a novel P-glycoprotein-like transporter modulator","volume":"45","author":"JM Perez-Victoria","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"ref105","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/j.1365-2958.2007.05653.x","article-title":"A novel ATP-binding cassette transporter from <italic>Leishmania<\/italic> is involved in transport of phosphatidylcholine analogues and resistance to alkyl-phospholipids","volume":"64","author":"E Castanys-Munoz","year":"2007","journal-title":"Mol Microbiol"},{"key":"ref106","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1128\/AAC.00587-08","article-title":"Characterization of an ABCG-like transporter from the protozoan parasite <italic>Leishmania<\/italic> with a role in drug resistance and transbilayer lipid movement","volume":"52","author":"E Castanys-Munoz","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"ref107","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1128\/AAC.49.7.2677-2686.2005","article-title":"Alteration of fatty acid and sterol metabolism in miltefosine-resistant <italic>Leishmania donovani<\/italic> promastigotes and consequences for drug-membrane interactions","volume":"49","author":"M Rakotomanga","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref108","doi-asserted-by":"crossref","first-page":"4807","DOI":"10.1111\/febs.12449","article-title":"Miltefosine-unresponsive <italic>Leishmania donovani<\/italic> has a greater ability than miltefosine-responsive L. donovani to resist reactive oxygen species","volume":"280","author":"M Das","year":"2013","journal-title":"FEBS J"},{"issue":"6","key":"ref109","doi-asserted-by":"crossref","first-page":"e0005641","DOI":"10.1371\/journal.pntd.0005641","article-title":"Increased miltefosine tolerance in clinical isolates of <italic>Leishmania donovani<\/italic> is associated with reduced drug accumulation, increased infectivity and resistance to oxidative stress","volume":"11","author":"DK Deep","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"ref110","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.exppara.2013.08.004","article-title":"Miltefosine resistance in <italic>Leishmania donovani<\/italic> involve suppression of oxidative stress-induced programmed cell death","volume":"135","author":"J Mishra","year":"2013","journal-title":"Exp Parasitol"},{"issue":"2","key":"ref111","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/clinids\/12.2.308","article-title":"Amphotericin B: 30 years of clinical experience","volume":"12","author":"HA Gallis","year":"1990","journal-title":"Rev Infect Dis"},{"key":"ref112","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0065-308X(05)61006-8","article-title":"Chemotherapy in the treatment and control of leishmaniasis","volume":"61","author":"J Alvar","year":"2006","journal-title":"Adv Parasitol"},{"issue":"2","key":"ref113","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00253-005-1955-9","article-title":"Amphotericin B","volume":"68","author":"A Lemke","year":"2005","journal-title":"Appl Microbiol Biotechnol"},{"issue":"1","key":"ref114","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s002329900086","article-title":"Amphotericin B kills unicellular leishmanias by forming aqueous pores permeable to small cations and anions","volume":"152","author":"H Ramos","year":"1996","journal-title":"J Membr Biol"},{"issue":"7","key":"ref115","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1073\/pnas.1117280109","article-title":"Amphotericin primarily kills yeast by simply binding ergosterol","volume":"109","author":"KC Gray","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"ref116","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nchembio.1496","article-title":"Amphotericin forms an extramembranous and fungicidal sterol sponge","volume":"10","author":"TM Anderson","year":"2014","journal-title":"Nat Chem Biol"},{"issue":"1","key":"ref117","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1016\/S2214-109X(13)70118-9","article-title":"Efficacy and safety of single-dose liposomal amphotericin B for visceral leishmaniasis in a rural public hospital in Bangladesh: a feasibility study","volume":"2","author":"D Mondal","year":"2014","journal-title":"Lancet Glob Health"},{"issue":"6","key":"ref118","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1056\/NEJMoa0903627","article-title":"Single-dose liposomal amphotericin B for visceral leishmaniasis in India","volume":"362","author":"S Sundar","year":"2010","journal-title":"N Engl J Med"},{"issue":"1","key":"ref119","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1016\/S2214-109X(13)70151-7","article-title":"Single-dose liposomal amphotericin B: an effective treatment for visceral leishmaniasis","volume":"2","author":"PK Sinha","year":"2014","journal-title":"Lancet Glob Health"},{"issue":"10","key":"ref120","doi-asserted-by":"crossref","first-page":"e1001692","DOI":"10.1371\/journal.pbio.1001692","article-title":"Fitness trade-offs restrict the evolution of resistance to amphotericin B","volume":"11","author":"BM Vincent","year":"2013","journal-title":"PLoS Biol"},{"issue":"10","key":"ref121","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1128\/AAC.00477-13","article-title":"Candida tropicalis antifungal cross-resistance is related to different azole target (Erg11p) modifications","volume":"57","author":"A Forastiero","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"ref122","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1128\/AAC.32.5.702","article-title":"Role of cell defense against oxidative damage in the resistance of <italic>Candida albicans<\/italic> to the killing effect of amphotericin B","volume":"32","author":"M Sokol-Anderson","year":"1988","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"ref123","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1128\/AAC.47.9.2717-2724.2003","article-title":"Disruption of ergosterol biosynthesis confers resistance to amphotericin B in Candida lusitaniae","volume":"47","author":"LY Young","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"ref124","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1128\/AAC.00030-11","article-title":"Mechanism of amphotericin B resistance in clinical isolates of <italic>Leishmania donovani<\/italic>","volume":"56","author":"B Purkait","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"ref125","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.1128\/JCM.00173-11","article-title":"Unusual case of resistance to amphotericin B in visceral leishmaniasis in a region in India where leishmaniasis is not endemic","volume":"49","author":"P Srivastava","year":"2011","journal-title":"J Clin Microbiol"},{"issue":"1","key":"ref126","doi-asserted-by":"crossref","first-page":"e0004304","DOI":"10.1371\/journal.pntd.0004304","article-title":"Antimony to Cure Visceral <italic>Leishmania<\/italic>sis Unresponsive to Liposomal Amphotericin B","volume":"10","author":"G Morizot","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"ref127","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12879-017-2192-4","article-title":"A severe case of visceral leishmaniasis and liposomal amphotericin B treatment failure in an immunosuppressed patient 15 years after exposure","volume":"17","author":"A Eichenberger","year":"2017","journal-title":"BMC Infect Dis"},{"issue":"2","key":"ref128","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1128\/AAC.42.2.352","article-title":"Mechanism of amphotericin B resistance in <italic>Leishmania donovani<\/italic> promastigotes","volume":"42","author":"N Mbongo","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"ref129","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.1128\/AAC.49.8.3274-3280.2005","article-title":"Production and characterization of stable amphotericin-resistant amastigotes and promastigotes of <italic>Leishmania mexicana<\/italic>","volume":"49","author":"HI Al-Mohammed","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"ref130","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1051\/parasite\/2001084335","article-title":"No evidence of oxidant events in amphotericin B cytotoxicity versus <italic>L<\/italic>. <italic>infantum<\/italic> promastigotes","volume":"8","author":"N Azas","year":"2001","journal-title":"Parasite"},{"issue":"7","key":"ref131","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1128\/AAC.48.7.2409-2414.2004","article-title":"Cloning of S-adenosyl-L-methionine:C-24-Delta-sterol-methyltransferase (ERG6) from <italic>Leishmania donovani<\/italic> and characterization of mRNAs in wild-type and amphotericin B-Resistant promastigotes","volume":"48","author":"M Pourshafie","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"ref132","doi-asserted-by":"crossref","first-page":"e0005649","DOI":"10.1371\/journal.pntd.0005649","article-title":"Sterol 14\u03b1-demethylase mutation leads to amphotericin B resistance in <italic>Leishmania mexicana<\/italic>","volume":"11","author":"R Mwenechanya","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"ref133","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ijpddr.2014.05.002","article-title":"Quantitative proteomic analysis of amphotericin B resistance in <italic>Leishmania infantum<\/italic>","volume":"4","author":"MC Brotherton","year":"2014","journal-title":"Int J Parasitol Drugs Drug Resist"},{"issue":"10","key":"ref134","doi-asserted-by":"crossref","first-page":"6172","DOI":"10.1128\/AAC.02834-14","article-title":"Ascorbate peroxidase, a key molecule regulating amphotericin B resistance in clinical isolates of Leishmania <italic>donovani<\/italic>","volume":"58","author":"A Kumar","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"ref135","doi-asserted-by":"crossref","first-page":"e0005171","DOI":"10.1371\/journal.pntd.0005171","article-title":"Different Mutations in a P-type ATPase Transporter in <italic>Leishmania<\/italic> Parasites are Associated with Cross-resistance to Two Leading Drugs by Distinct Mechanisms","volume":"10","author":"C Fernandez-Prada","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"issue":"9764","key":"ref136","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0140-6736(10)62050-8","article-title":"Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial","volume":"377","author":"S Sundar","year":"2011","journal-title":"Lancet"},{"issue":"6","key":"ref137","doi-asserted-by":"crossref","first-page":"e1674","DOI":"10.1371\/journal.pntd.0001674","article-title":"Sodium stibogluconate (SSG) &amp; paromomycin combination compared to SSG for visceral leishmaniasis in East Africa: a randomised controlled trial","volume":"6","author":"A Musa","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"issue":"9","key":"ref138","doi-asserted-by":"crossref","first-page":"e0004880","DOI":"10.1371\/journal.pntd.0004880","article-title":"Efficacy and Safety of AmBisome in Combination with Sodium Stibogluconate or Miltefosine and Miltefosine Monotherapy for African Visceral Leishmaniasis: Phase II Randomized Trial.","volume":"10","author":"M Wasunna","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"ref139","doi-asserted-by":"crossref","first-page":"e0004495","DOI":"10.1371\/journal.pntd.0004495","article-title":"Treatment of Cutaneous Leishmaniasis Caused by <italic>Leishmania aethiopica<\/italic>: A Systematic Review","volume":"10","author":"J van Griensven","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"ref140","unstructured":"WHO. Control of the leishmaniasis: report of a meeting of the World Health Organization Expert Committee on the Control of Leishmaniases. Geneva, 22\u201326 March 2010. World Health Organization Technical Report Series 949, 1\u2013186."},{"issue":"2","key":"ref141","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.trstmh.2010.10.008","article-title":"Ambisome plus miltefosine for Indian patients with kala-azar","volume":"105","author":"S Sundar","year":"2011","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"1","key":"ref142","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4269\/ajtmh.2007.77.89","article-title":"Treatment of kala-azar in southern Sudan using a 17-day regimen of sodium stibogluconate combined with paromomycin: a retrospective comparison with 30-day sodium stibogluconate monotherapy","volume":"77","author":"Y Melaku","year":"2007","journal-title":"Am J Trop Med Hyg"},{"key":"ref143","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/1745-6215-12-166","article-title":"Safety and efficacy of miltefosine alone and in combination with sodium stibogluconate and liposomal amphotericin B for the treatment of primary visceral leishmaniasis in East Africa: study protocol for a randomized controlled trial","volume":"12","author":"R Omollo","year":"2011","journal-title":"Trials"},{"issue":"4","key":"ref144","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1128\/AAC.04231-14","article-title":"Experimental resistance to drug combinations in <italic>Leishmania donovani<\/italic>: metabolic and phenotypic adaptations","volume":"59","author":"M Berg","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"ref145","doi-asserted-by":"crossref","first-page":"e0003704","DOI":"10.1371\/journal.pntd.0003704","article-title":"Fitness of <italic>Leishmania donovani<\/italic> parasites resistant to drug combinations","volume":"9","author":"R Garc\u00eda-Hern\u00e1ndez","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"ref146","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1475-9292-2-14","article-title":"Physiological consequences of drug resistance in <italic>Leishmania<\/italic> and their relevance for chemotherapy","volume":"2","author":"A Ponte-Sucre","year":"2003","journal-title":"Kinetoplastid Biol Dis"}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0006052","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,24]],"date-time":"2020-10-24T09:02:55Z","timestamp":1603530175000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0006052"}},"subtitle":[],"editor":[{"given":"Louis","family":"Maes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,12,14]]},"references-count":146,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2017,12,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0006052","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,14]]}}}